High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation

Human Gene Therapy

Volumn 8, Issue 9, 1997, Pages 1025-1032

  Zeng, Ming ^a   Cerniglia, George J ^a   Eck, Stephen L ^a   Stevens, Craig W ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DNA; VIRUS DNA;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA INTEGRATION; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IONIZING RADIATION; MAMMAL CELL; METHODOLOGY; MOUSE; NONHUMAN; RADIATION DOSE;

ADENOVIRIDAE; ANIMALIA; MAMMALIA; RODENTIA;

EID: 0030743963     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.9-1025     Document Type: Article

References (41)

1. ALEXANDER, I.E., RUSSELL, D.W., SPENCE, A.M., and MILLER, A.D. (1996). Effects of gamma irradiation on the transduction of dividing and non-dividing cells in brain and muscle of rats by adeno-associated virus vector. Hum. Gene Ther. 7, 841-850.
2. BELEHRADEK, M., DOMENGE, C., LUBOINSKI, B., ORLOWSKI, S., and BELEHRADEK, J.J. (1993). Electrochemotherapy, a new anti-tumor treatment: First clinical phase I-II trial. Cancer 72, 3694-3700.
3. BETT, A.J., PREVEC, L., and GRAHAM, F.L. (1993). Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67, 5911-5921.
4. BRODY, S.L., JAFFE, H.A., HAN, S.K., WERSTO, R.P., and CRYSTAL, R.G. (1994). Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Hum. Gene Ther. 5, 437-447.
5. BROUGH, D.E., LIZONOVA, A., HSU, C., KULESA, V.A., and KOVESDI, I. (1996). A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J. Virol. 70, 497-501.
6. COUCH, R.B., CHANOCK, R.M., CATE, T.R., LANG, D.J., KNIGHT, V., and HUEBNER, R.J. (1963). Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. Am. Rev. Respir. Dis. 88, 394-403.
7. DEV, S.B., and HOFMANN, G.A. (1995). Electrical manipulation of cells. In Clinical Applications of Electroporation. P.T. Lynch and M.R. Davey, ed. (Chapman and Hall, New York) pp. 185-199.
8. DOERFLER, W. (1993). Adenoviral DNA integration and changes in DNA methylation patterns: A different view of insertional muta-genesis. Progr. Nucleic Acid Res. Mol. Biol. 46, 1-36.
9. ENGELHARDT, J.F., SIMON, R.H., YANG, Y., ZEPEDA, M., PENDLETON, S.W., DORANZ, B., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of non-human primates: Biological efficacy study. Hum. Gene Ther. 4, 759-769.
10. FRIEDMANN, T. (1989). Progress toward human gene therapy. Science 244, 1275-1281.
11. GINSBURG, H.S., MOLDAWER, L.L., SEHGAL, P.B., REDINGTON, M., KILIAN, P.L., CAHNOCK, R.M., and PRINCE, G.A. (1991). A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88, 1651-1655.
12. GOLDMAN, M.J., LITZKY, L.A., ENGELHARDT, J.F., and WILSON, J.M. (1995). Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: A preclinical toxicology study. Hum. Gene Ther. 6, 839-851.
13. GROSSMAN, M., RAPER, S.E., and WILSON, J.M. (1992). Transplantation of genetically modified autologous hepatocytes into nonhuman primates: Feasibility and short-term toxicity. Hum. Gene Ther. 3, 501-510.
14. GUTIERREZ, A.A., LEMOINE, N.R., and SIKORA, K. (1992). Gene therapy for cancer. The Lancet 339, 715-721.
15. HOROWITZ, M.S. (1990). Adenoviridae and their replication. In In Virology. B.N. Fields and D.M. Knipe, eds. (Raven Press, Limited, New York) pp. 1679-1721.
16. HALLAHAN, D.E., MAUCERI, H.J., SEUNG, L.P., DUNPHY, E.J., WAYNE, J.D., HANNA, N.N., TOLEDANO, A., HELLMAN, S., KUFE, D.W., and WEICHSELBAUM, R.R. (1995). Spatial and temporal control of gene therapy using ionizing radiation. Nature Med. 1, 786-791.
17. JAFFE, H.A., DANEL, G., LONGENECKER, G., METZGER, M., SETOGUCHI, Y., ROSENFELD, M.A., GANT, T.W., THORGEIRSSON, S.S., STRATFORD-PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378.
18. JOHNSON, L.G., PICKLES, R.J., BOYLES, S.E., MORRIS, J.C., YE, H., ZHOU, Z., OLSEN, J.C., and BOUCHER, R.C. (1996). In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia. Hum. Gene Ther. 7, 51-59.
19. KAY M.A., HOLTERMAN, A., MEUSE, L., GOWN, A., OCHS, H.D., LINSLEY, P.S., and WILSON, C.B. (1995). Long-term hepatic adenovirus-mediated gene expression in mice following CTLAIg administration. Nature Genet. 11, 191-197.
20. KOZARSKY, K., and WILSON, J.M. (1993). Gene therapy-adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
21. KRAYEV, A.S., MARKUSHEVA, T.V., KRAMEROV, D.A., RYSKOV, A.P., SKYRABIN, K.G., BAYEV, A.A., and GEORGIEV, B. (1982). Ubiquitous transposon-like repeats B1 and B2 of the mouse genome: B2 sequencing. Nucleic Acids Res. 10, 7461-7475.
22. MACLEOD, J.N., LEE, A.K., LIEBHABER, S.A., and COOKE, N.E. (1991). Developmental control and control and alternative splicing of the placentally expressed transcripts from the human growth hormone gene cluster. J. Biol. Chem. 267, 14219-14226.
23. MANOME, Y., WEN, P.Y., DONG, Y., TANAKA, T., MITCHELL, B.S., KUFE, D.W., and FINE, H.A. (1996). Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nature Med. 2, 567-573.
24. MATTHEWS, K.E., DEV, S.B., TONEGUZZO, F., and KEATING, A. (1995). Animal cell electroporation protocols. In Electroporation for Gene Therapy. J.A. Nickoloff, ed. (Humana Press Inc., Totowa, NJ) pp. 273-280.
25. MILLER, A.D. (1992). Human gene therapy comes of age. Nature 357, 455-460.
26. MIR, L.M., BANOUN, H., and PAOLETTI, C. (1988). Introduction of definite mounts of nonpermanent molecules into living cells after electropermeabilization: Direct access to the cytosol. Exp. Cell Res. 175, 15-25.
27. NISHI, T., YOSHIZATO, K., YAMASHIRO, S., TAKESHIMA, K., SATO, K., HAMADA, K., KITAMURA, I., YOSHIMURA, T., SAYA, H., KURATSU, J., and USHIO, Y. (1996). High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo elecroporation. Cancer Res. 56, 1050-1055.
28. NOLAN, G.P., FIERING, S., NICHOLAS, J.F., and HERZENBERG, L.A. (1988). Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl. Acad. Sci. USA 85, 2603-2607.
29. PALMER, T.D., ROSMAN, G.J., OSBORNE, W.R.A., and MILLER, A.D. (1991). Genetically modified skin fibroblast persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88, 1330-1334.
30. PODDEVIN, B., ORLOWSKI, S., BELEHRADEK, J.J., and MIR, L.M. (1991). Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol. 42, 567-575.
31. ROSS, G.M., EADT, J.J., MITHAL, N.P., GORDON STEEL, C.G., and JEGGO, P.A. (1995). DNA strand break rejoining defect in xrs-6 is complemented by transfection with the human ku80 gene. Cancer Res. 55, 1235-1238.
32. SMYTHE, W.R., HWANG, H.C., ELSHAMI, A.A., AMIN, K.M., ECK, S.L., DAVIDSON, B.L., WILSON, J.M., KAISER, L.R., and ALBELDA, S.M. (1995). Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simples thymidine kinase gen. Ann. Surg. 222, 78-86.
33. STEVENS, C.W., MANOHARAN, H., and FAHL, W.E. (1988). Characterization of mutagen-activated cellular oncogenes that confer anchorage independence to human fibroblasts and tumorigenicity to NIH 3T3 cells: Sequence analysis of an enzymatically amplified mutant HRAS allele. Proc. Natl. Acad. Sci. USA 85, 3875-3879.
34. STEVENS, C.W., ZENG, M., and CERNIGLIA, G. (1996). Ionizing radiation greatly improves gene transfer efficiency in mammalian cells. Hum. Gene Ther. 7, 1727-1734.
35. WILLS, K.N., HUANG, W.M., HARRIS, M.P., MACHEMER, T., MANEVAL, D.C., and GREGORY, R.J. (1995). Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther. 2, 191-197.
36. WILSON, J.M. (1993). Vehicles for gene therapy. Nature 365, 691-692.
37. WILSON, J.M. (1996). Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1177.
38. YANG, Y., ERTL, H., and WILSON, J. (1994). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442.
39. ZHENG, Q., and CHANG, D.C. (1991). High-efficiency gene transfection by in situ electroporation of cultured cells. Biochim. Biophys. Acta 1088, 104-110.
40. ZIMMERMAN, U. (1982). Electric field-mediated fusion and related electrical phenomena. Biochim. Biophys. Acta 694, 227-277.
41. ZSUZSANNA, K., ZSENGELLER, S.W., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient mice. Hum. Gene Ther. 6, 457-467.